SpaceX shares spiked in premarket trading on Wednesday following Elon Musk’s announcement that a special committee has been formed to explore a potential merger with Tesla. The move, which Musk described as a "good idea," has energized investors despite looming capital requirements and regulatory complexities.
What Happened
Elon Musk revealed that a special committee is now in place to evaluate the combination of SpaceX and Tesla. Musk stated that he represents a "conflicted party," meaning he will not be included in the discussions. If completed, the deal would represent the largest merger in history, creating a giant company worth roughly 3 and a half trillion dollars. Tesla shares were also moving higher in early trading.
The merger talk coincided with a blowout set of numbers for SpaceX, which reported third-quarter revenues jumping 161%, soaring past expectations. However, analysts like Julie Zhu of MoffettNathanson highlighted the "enormous calls on capital that loom over the next few years."
Why It Matters
The potential merger is driven by strategic synergies, particularly around the existing joint venture Terafab. Terafab aims to test its first SRAM chip by June next year, targeting one terawatt a year of computing power. Musk said a full merger would mean there is "a lot to be gained from cooperating on developing superintelligence software." Gene Munster of Deepwater Asset Management characterized the deal as a "slam dunk" if it comes down to shareholder approval, predicting it would create the "most unique company in the world."
However, the aggressive timeline for Terafab depends on acquiring complex equipment from suppliers like ASML, Applied Materials, and KLA. Investors are also monitoring broader market sentiment, with Tesla facing headwinds from a 2% year-on-year decline in delivery numbers, although that is ahead of estimates.
The Bottom Line
While the prospect of a merger worth roughly 3 and a half trillion dollars has buoyed SpaceX and Tesla stock prices, the path forward involves significant capital expenditures and supply chain dependencies. The market remains focused on the execution of the Terafab joint venture and the upcoming earnings reports from both companies, which are due after the bell on Wednesday.